Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Rivaroxaban is broadly used for the primary prevention of stroke and systemic embolism in the general population with non-valvular atrial fibrillation (AF). However, there is little published evidence on the safety and efficacy of rivaroxaban for AF in patients with active cancer. The aim of this st...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Cardiol
Hoofdauteurs: Laube, Eva S, Yu, Anthony, Gupta, Dipti, Miao, Yimei, Samedy, Patrick, Wills, Jonathan, Harnicar, Stephen, Soff, Gerald A., Mantha, Simon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523442/
https://ncbi.nlm.nih.gov/pubmed/28549819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.04.009
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items